Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.58 |
| ▸ | TSHR | P16473 | 6/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | CA7 | P43166 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 2/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | APP | P05067 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30969126 | 1.00 | MEN1 (0.58) | MEN1KMT2ATSHRMAPK1POLB | |
| SCHEMBL15103276 | 1.00 | MEN1 (0.58) | MEN1KMT2ATSHRMAPK1POLB | |
| SCHEMBL13755793 | 1.00 | MEN1 (0.58) | MEN1KMT2ATSHRMAPK1POLB | |
| SCHEMBL16491144 | 1.00 | MEN1 (0.58) | MEN1KMT2ATSHRMAPK1POLB | |
| SCHEMBL3663413 | 1.00 | MEN1 (0.58) | MEN1KMT2ATSHRMAPK1POLB | |
| SCHEMBL16491141 | 1.00 | MEN1 (0.58) | MEN1KMT2ATSHRMAPK1POLB | |
| SCHEMBL426095 | 1.00 | MEN1 (0.58) | MEN1KMT2ATSHRMAPK1POLB | |
| SCHEMBL7884151 | 1.00 | MEN1 (0.58) | MEN1KMT2ATSHRMAPK1POLB | |
| SCHEMBL7879363 | 1.00 | MEN1 (0.58) | MEN1KMT2ATSHRMAPK1POLB | |
| SCHEMBL28443499 | 1.00 | MEN1 (0.58) | MEN1KMT2ATSHRMAPK1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 603 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023235688-A1 | FORMULATION FOR TRANSDERMAL DELIVERY | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-12-07 | — | — | WO | claimed |
| CN-111373014-B | Robust alkyl ether sulfate mixtures for enhanced oil recovery | 巴斯夫欧洲公司 | 2023-10-27 | — | — | CN | claimed |
| CN-116925318-A | Polyurethane matrix material, preparation method and application | 万华化学集团股份有限公司 | 2023-10-24 | — | — | CN | claimed |
| EP-3976362-B1 | METHOD FOR MAKING OPAQUE COLORED SILICONE HYDROGEL CONTACT LENSES | ALCON INC (CH) | 2023-06-07 | — | — | EP | claimed |
| US-11584097-B2 | Method for making opaque colored silicone hydrogel contact lenses | ALCON INC. (CH) | 2023-02-21 | — | — | US | claimed |
| CN-111472183-B | Acid dye ink composition and manufacturing method thereof | 福盈科技化学股份有限公司 | 2022-10-28 | — | — | CN | claimed |
| EP-3976362-A1 | METHOD FOR MAKING OPAQUE COLORED SILICONE HYDROGEL CONTACT LENSES | Alcon Inc. (CH) | 2022-04-06 | — | — | EP | claimed |
| EP-3398958-B1 | POLYAMINOACID, PROTEIN-POLYAMINOACID CONJUGATE AND PREPARATION METHOD THEREFOR | UNIV BEIJING (CN) | 2022-02-23 | — | — | EP | claimed |
| WO-2021039685-A1 | COLORING FLUID, COLORING FLUID SET, RECORDING MEDIUM, AND COLORING METHOD | 日本化薬株式会社 | 2021-03-04 | — | — | WO | claimed |
| US-20200376787-A1 | METHOD FOR MAKING OPAQUE COLORED SILICONE HYDROGEL CONTACT LENSES | ALCON INC. (CH) | 2020-12-03 | — | — | US | claimed |
| EP-0485161-A1 | Stripping compositions and method of stripping resists from substrates | EKC TECHNOLOGY, INC. (US) | 1992-05-13 | — | — | EP | claimed |
| US-5043390-A | Fluoroolefin-alkene base copolymer useful as paint vehicle | CENTRAL GLASS COMPANY, LIMITED (JP) | 1991-08-27 | — | — | US | claimed |
| US-4985519-A | FLUOROOLEFIN, VINYL ESTER, HYDROXYL-CONTAINING ALLYL ETHER, AND CARBOXYL-CONTAINING MONOMER | CENTRAL GLASS COMPANY, LIMITED (JP) | 1991-01-15 | — | — | US | claimed |
| EP-0391232-A1 | Fluoroolefin-alkene base copolymer useful as paint vehicle | CENTRAL GLASS COMPANY, LIMITED (JP) | 1990-10-10 | — | — | EP | claimed |
| US-4954589-A | FLUOROOLEFIN, VINYL OR ISOPROPENYL ESTER, HYDROXYALLYL ETHER, ACRYLIC TYPE ACID OR ANHYDRIDE | CENTRAL GLASS COMPANY, LIMITED (JP) | 1990-09-04 | — | — | US | claimed |
| US-4808235-A | SPRAYING BLADES WITH MIXTURES OF GLYCOL ETHERS, ADD WCTS OR POLYETHERS; ON-LINE | THE DOW CHEMICAL COMPANY (US) | 1989-02-28 | — | — | US | claimed |
| EP-0275987-A2 | Composition and method for cleaning gas turbine compressors | THE DOW CHEMICAL COMPANY (US) | 1988-07-27 | — | — | EP | claimed |
| US-4631326-A | CHLOROTHIFLUOROETHYLENE, VINYL ESTER, ALLYL ETHER MONOMERS; PAINTS | CENTRAL GLASS COMPANY LIMITED (JP) | 1986-12-23 | — | — | US | claimed |
| EP-0074335-B1 | STORAGE-STABLE MOTH-PROOFING FORMULATIONS | CIBA-GEIGY AG (CH) | 1985-11-27 | — | — | EP | claimed |
| US-4502861-A | 5-PHENYLCARBAMOXYLBARBITURIC ACID AND SYNTHETIC PYRETHROID | CIBA-GEIGY CORPORATION (US) | 1985-03-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11584097-B2 | Method for making opaque colored silicone hydrogel contact lenses | COIL, CRYAB, CRYAA | MEN1 54/4885KMT2A 1854/4885TSHR 3017/4885 |
| US-20200376787-A1 | METHOD FOR MAKING OPAQUE COLORED SILICONE HYDROGEL CONTACT LENSES | COIL, CRYAB, CRYAA | MEN1 54/4885KMT2A 1854/4885TSHR 3017/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.